5 amino 1mq with nad+ 5-Amino-1MQ 50mg Capsules | CAS 42464-96-0 – BioPeptide 5-Amino-1MQ / MOTS-C / NAD+

Changes to the microbial phyla and genera observed in the 5A-1MQ-treated group switched from WD to LD could have been driven by additive, synergistic, or independent mechanisms relative to those induced by diet switch alone, which could not be determined with the current study design that lacked a group treated with 5A-1MQ and maintained on WD

For broader peptide reconstitution context, see our reconstitution reference guide

Do not force-feed

Kruis, T., Batra, A

Based on preclinical (animal and cellular) data only, inhibition of NNMT by 5-Amino-1MQ is theorised to: Raise intracellular NAD+ levels Activate SIRT1 and other sirtuins (proteins linked to metabolic regulation) Reduce fat cell (adipocyte) size and proliferation Improve insulin sensitivity These effects have been demonstrated in mouse models (Neelakantan et al., 2019), but robust human clinical trial data are currently absent

This dose is often enough to treat most deficiencies